Table 2.
Calendar Year | 1994–1995 | 1996–1997 | 1998–1999 | 2000–2001 | 2002–2003 | 2004–2005 | |
---|---|---|---|---|---|---|---|
Total U.S population aged 0–74 years, in millions | 249.9 | 255.5 | 261.2 | 266.8 | 271.6 | 276.5 | |
Acute Myeloid Leukemia (AML) | Incidence rate per 100,000 persons | 5.2 | 5.0 | 5.2 | 5.5 | 5.0 | 4.7 |
Number of new incident cases aged 0–74 years | 12,879 | 12,683 | 13,682 | 14,608 | 13,532 | 13,131 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | 6.6% | 5.3% | 5.5% | 3.9% | 4.8% | 5.0% | |
Acute Lymphoblastic Leukemia (ALL) | Incidence rate per 100,000 persons | 2.9 | 3.0 | 3.0 | 3.0 | 3.1 | 3.3 |
Number of new incident cases aged 0–74 years | 7,706 | 7,592 | 7,926 | 8,055 | 8,404 | 9,067 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | 2.6% | 1.5% | 1.3% | 0.7% | 0.4% | 0.6% | |
Myelodysplastic syndrome/ Myeloproliferative disorder (MDS/MPS) | Incidence rate per 100,000 persons | * | * | * | * | 3.8 | 3.9 |
Number of new incident cases aged 0–74 years | * | * | * | * | 10,226 | 10,764 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | * | * | * | * | 0.2% | 0.2% | |
Non-Hodgkin lymphoma (NHL) | Incidence rate per 100,000 persons | 29.5 | 28.4 | 27.9 | 28.0 | 28.7 | 29.4 |
Number of new incident cases aged 0–74 years | 73,658 | 72,650 | 72,925 | 74,614 | 77,973 | 81,272 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | 4.9% | 5.9% | 5.6% | 5.3% | 4.6% | 4.5% | |
Hodgkin Lymphoma (HL) | Incidence rate per 100,000 persons | 5.1 | 5.2 | 5.3 | 5.1 | 5.2 | 5.3 |
Number of new incident cases aged 0–74 years | 12,787 | 13,330 | 13,856 | 13,707 | 14,212 | 14,706 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | 9.4% | 10.0% | 10.8% | 10.1% | 10.0% | 10.3% | |
Multiple Myeloma (MM) | Incidence rate per 100,000 persons | 7.4 | 7.4 | 7.5 | 7.7 | 7.7 | 8.0 |
Number of new incident cases aged 0–74 years | 18,422 | 19,006 | 19,498 | 20,468 | 20,863 | 22,123 | |
Rate of AutoHCTs aged 0–74 years per New Incident cases | 5.1% | 9.8% | 15.6% | 18.3% | 22.6% | 25.1% |
SEER did not initiate data collection for MDS/MPD until 2001.